Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

fiftheye.com

Founded Year

2017

Stage

Convertible Note - II | Alive

Total Raised

$21.51M

Last Raised

$5.4M | 5 mos ago

About Fifth Eye

Fifth Eye is a predictive analytics company providing real-time predictive analytics for Hemodynamic Instability. The company was founded in 2017 and is based in Ann Arbor, Michigan.

Fifth Eye Headquarters Location

110 Miller Ave Suite 300

Ann Arbor, Michigan, 48104,

United States

ESPs containing Fifth Eye

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Healthcare Payers Tech

Companies in this market develop software that collects, analyzes, and aggregates clinical and claims data to identify population-level trends. These technologies can deliver actionable information for improving clinical outcomes and cost-effectiveness at scale, especially as ongoing consolidation within the payer and provider spaces brings together large volumes of data.

Fifth Eye named as Outperformer among 15 other companies, including Evidation, Aetion, and HealthVerity.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Fifth Eye

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Fifth Eye is included in 4 Expert Collections, including Value-Based Care & Population Health.

V

Value-Based Care & Population Health

1,076 items

The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.

M

Medical Devices

12,003 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

D

Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

7,901 items

Fifth Eye Patents

Fifth Eye has filed 2 patents.

The 3 most popular patent topics include:

  • Cardiac arrhythmia
  • Intensive care medicine
  • Neurotrauma
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/11/2018

11/26/2019

Beta blockers, Psychiatric diagnosis, Cardiac arrhythmia, Intensive care medicine, Neurotrauma

Grant

Application Date

12/11/2018

Grant Date

11/26/2019

Title

Related Topics

Beta blockers, Psychiatric diagnosis, Cardiac arrhythmia, Intensive care medicine, Neurotrauma

Status

Grant

Latest Fifth Eye News

Fifth Eye Appoints Eric Pergler as Vice President of Sales

Aug 16, 2022

News provided by Share this article Share this article ANN ARBOR, Mich., Aug. 16, 2022 /PRNewswire/ -- Fifth Eye TM, a provider of intuitive real-time clinical analytics, is excited to announce the appointment of Eric Pergler as Vice President Sales. Eric has over 20 years of experience in commercial roles including executive sales leadership in medical devices. Eric will be responsible for driving sales of Fifth Eye's flagship product, the AHI System™. The AHI System is FDA-cleared medical device software designed to reduce preventable adverse events by facilitating early awareness of potentially serious emerging problems – ahead of vital signs – in adult patients throughout the hospital. Additionally, the AHI System facilitates reduced lengths of stay by augmenting clinicians' judgment with objective, validated information to support timely step-down or discharge decisions. "We are delighted to welcome Eric to our executive team," said Jen Baird, CEO, Fifth Eye. "Eric brings a track record of demonstrated success in driving adoption of disruptive medical technologies. We are looking forward to his leadership to help us bring the benefits of the AHI System to new hospitals, clinicians, and patients." Prior to joining Fifth Eye, Eric held sales leadership roles at Centerline Biomedical and Veran Medical Technologies. Eric has played a key role in shaping and executing successful commercial strategies in companies from initial commercialization through emerging growth phases. He has a passion for bringing disruptive technology to the marketplace, building winning teams, and ultimately making an impact to improve patient care. Eric has a Bachelor of Science in Mechanical Engineering from Western Michigan University. Clinicians overburdened by low staffing and increased administrative demands need help to prioritize their time where it is most needed. The AHI System continuously detects, trends and predicts the risk of hemodynamic instability of adult patients throughout the hospital. The AHI System has been shown to predict future episodes of instability 48 minutes ahead of vital signs in an ICU and hours earlier in lower acuity settings. Clinicians enjoy "at-a-glance" awareness of the evolving hemodynamic trajectory of monitored patients on a multi-patient screen. And that screen can be accessed by any member of the care team on any device with a web-enabled browser (e.g., phone, computer, wall monitor, etc.). About Fifth Eye Inc. Fifth Eye, Inc. is an Ann Arbor, Michigan-based company that develops intuitive, real-time clinical analytics based on physiologic waveforms to improve outcomes and reduce costs. The AHI System™ is the first and only FDA-cleared clinical decision support software that continuously predicts the risk of hemodynamic instability earlier than vital signs. AI-powered AHI extracts information embedded in a Lead II ECG signal alone – no manual or other inputs required. Fifth Eye's machine-learning technology is licensed from the University of Michigan. For more information, please visit www.fiftheye.com . Media Contact:

Apr 26, 2022
News 4/27/22

Fifth Eye Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Fifth Eye Rank

  • When was Fifth Eye founded?

    Fifth Eye was founded in 2017.

  • Where is Fifth Eye's headquarters?

    Fifth Eye's headquarters is located at 110 Miller Ave, Ann Arbor.

  • What is Fifth Eye's latest funding round?

    Fifth Eye's latest funding round is Convertible Note - II.

  • How much did Fifth Eye raise?

    Fifth Eye raised a total of $21.51M.

  • Who are the investors of Fifth Eye?

    Investors of Fifth Eye include Invest Michigan, Arboretum Ventures, Cultivation Capital, MINTS, Biosciences Research and Commercialization Center and 4 more.

  • Who are Fifth Eye's competitors?

    Competitors of Fifth Eye include Flashback Technologies.

You May Also Like

Bayesian Health Logo
Bayesian Health

Bayesian Health provides machine learning-driven end-to-end protocols that give care teams actionable information in real-time to enable rapid and sustainable performance improvement. The company's platform provides accurate and actionable clinical signals to empower physicians and caregivers to diagnose, intervene, and deliver higher-quality care. Bayesian Health was founded in 2016 and is based in New York, New York.

F
Flashback Technologies

Flashback Technologies is commercializing a new vital sign with broad applications in healthcare and human performance – The Compensatory Reserve Index (CRI). Early stage commercialization is underway with two FDA cleared devices. Its non-invasive, easy-to-use vital sign monitor trends change in intravascular volume and estimates an individual’s tolerance to additional volume loss before collapse. Compared to traditional vital signs, CRI provides early insight that enables intervention that can reduce costs, improve outcomes and save lives.

Edwards Lifesciences Logo
Edwards Lifesciences

Edwards Lifesciences (NYSE: EW) is a medical equipment and devices company that designs, manufactures, and markets tissue heart valves and related repair products. The company also provides solutions in enhanced surgical recovery, clot management, infection control, anesthesia, hospital administration, annuloplasty rings, catheters, hemodynamic monitoring, and more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.